Yahoo! Finance: Top Stories

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating

Jun 17, 2025 - 10:14
 0
Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating
Read More

Tags:

Previous Article

GSK Licenses Shigella Vaccine to Bharat Biotech

Next Article

Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook

Related Posts

Solar Power Stocks Rally On Tax-Credit Move; This Stock Tops Buy Point

Solar Power Stocks Rally On Tax-Credit Move; This Stock...

May 13, 2025  0

Jim Cramer Notes Super Micro Computer (SMCI) Is “Relatively Cheap Versus the Whole Cohort”

Jim Cramer Notes Super Micro Computer (SMCI) Is “Relati...

May 19, 2025  0

Treasury's Bessent says US is 'never going to default' as debt limit deadline looms

Treasury's Bessent says US is 'never going to default' ...

Jun 4, 2025  0